PeerVoice Endocrinology & Metabolic Disorders Audio-logo

PeerVoice Endocrinology & Metabolic Disorders Audio

Education Podcasts

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Location:

United States

Description:

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Language:

English


Episodes

Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs

4/28/2022
Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs

Duration:00:33:50

State of the Science in CKD: New Treatment, New Outcomes

12/27/2021
State of the Science in CKD: New Treatment, New Outcomes

Duration:00:17:33

Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?

12/20/2021
Novel Targets in T2DM: Incretin Co-Agonists to the Rescue?

Duration:00:24:02

Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach

12/20/2021
Individualising Glycaemic Targets in Type 2 Diabetes and Obesity: A Case-Based Approach

Duration:00:20:26

Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?

11/9/2021
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?

Duration:00:35:52

Taking Aim in Type 2 Diabetes: New Guidelines and Targets for Clinical Practice

11/9/2021
Taking Aim in Type 2 Diabetes: New Guidelines and Targets for Clinical Practice

Duration:00:22:43

Incretin Effect 101: Why We Need to Look Beyond GLP-1 in T2DM

11/3/2021
Incretin Effect 101: Why We Need to Look Beyond GLP-1 in T2DM

Duration:00:22:12

The Science of Weight Loss: Why “Eat Less, Move More” Fails and Why We Need to Do More

11/1/2021
The Science of Weight Loss: Why “Eat Less, Move More” Fails and Why We Need to Do More

Duration:00:23:16

Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs

10/21/2021
Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs

Duration:00:10:07

A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes

10/14/2021
A Multidisciplinary Approach to Prevention and Management of CKD in T2DM: Best Practices for Optimal Outcomes

Duration:00:28:52

The Holistic Care of Patients with T2DM: Going Beyond HbA1c

9/27/2021
The Holistic Care of Patients with T2DM: Going Beyond HbA1c

Duration:00:23:06

Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies

9/27/2021
Understanding the Impact of Gene Fusion Detection in NSCLC: The Latest Updates on Testing and Treatment Strategies

Duration:00:15:39

Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care

9/6/2021
Clinical Conundrums in Type 2 Diabetes: Managing Challenging Cases in Primary Care

Duration:00:25:46

Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!

8/31/2021
Optimising Use of Traditional Oral Glucose-Lowering Therapies in Type 2 Diabetes: Important for Patients and Society!

Duration:00:17:06

Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes

8/10/2021
Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes

Duration:00:31:26

Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes

8/6/2021
Personalising Care Across the Disease Continuum: From Prediabetes Through Type 2 Diabetes

Duration:00:44:01

Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress

7/16/2021
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress

Duration:00:08:38

Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021

6/23/2021
Evaluating the Evidence for Managing CKD: Highlights From World Congress of Nephrology 2021

Duration:00:08:43

Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs

6/17/2021
Step-by-Step: Setting a Course for Long-Term Control of Type 2 Diabetes With GLP-1 RAs

Duration:00:21:14

Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin

6/10/2021
Why Combination Therapies and Why Now? The Rationale and Role of GLP-1 RAs and Insulin

Duration:00:32:51